Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-18 5:16 pm Purchase |
2023-08-16 | 13D | Taysha Gene Therapies, Inc. TSHA |
Astellas Pharma Inc. | 7,266,342 3.890% |
7,266,342 (New Position) |
Filing History |
| 2023-02-09 12:39 pm Sale |
2023-02-09 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 3,204,922 5.132% |
-69,635 (-2.13%) |
Filing History |
| 2022-11-10 11:55 am Sale |
2022-11-09 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 3,274,557 5.951% |
-1,005,937 (-23.50%) |
Filing History |
| 2022-11-02 4:02 pm Purchase |
2022-10-31 | 13D | Taysha Gene Therapies, Inc. TSHA |
Manning Paul B | 6,989,861 11.200% |
1,694,554 (+32.00%) |
Filing History |
| 2022-10-31 4:02 pm Purchase |
2022-10-21 | 13D | Taysha Gene Therapies, Inc. TSHA |
Audentes Therapeutics Inc. BOLD |
7,266,342 11.600% |
7,266,342 (New Position) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Taysha Gene Therapies, Inc. TSHA |
BLACKROCK INC BLK |
1,046,490 2.600% |
-1,986,473 (-65.50%) |
Filing History |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 4,280,494 11.125% |
-1,383,721 (-24.43%) |
Filing History |
| 2022-02-07 4:41 pm Purchase |
2021-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
BLACKROCK INC BLK |
3,032,963 7.900% |
803,147 (+36.02%) |
Filing History |
| 2021-09-23 6:56 pm Sale |
2021-09-22 | 13G | Taysha Gene Therapies, Inc. TSHA |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,156,255 3.010% |
-1,022,745 (-46.94%) |
Filing History |
| 2021-02-16 1:35 pm Purchase |
2020-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,179,000 5.770% |
2,179,000 (New Position) |
Filing History |
| 2021-02-08 10:33 am Purchase |
2021-02-05 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 5,664,215 14.999% |
1,456,641 (+34.62%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
BLACKROCK INC BLK |
2,229,816 5.900% |
2,229,816 (New Position) |
Filing History |
| 2020-10-13 10:35 am Purchase |
2020-10-12 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 4,207,574 11.374% |
4,207,574 (New Position) |
Filing History |
| 2020-10-05 5:26 pm Purchase |
2020-09-23 | 13D | Taysha Gene Therapies, Inc. TSHA |
Manning Paul B | 5,295,307 14.300% |
5,295,307 (New Position) |
Filing History |
| 2020-10-05 4:58 pm Purchase |
2020-09-23 | 13D | Taysha Gene Therapies, Inc. TSHA |
Session R.A. II | 9,430,582 25.500% |
9,430,582 (New Position) |
Filing History |